• Explore /
  • Poster
  • / Neoadjuvant dual checkpoint inhibition followed by immune-chemoradiation in patients with resectable gastric adenocarcinoma.

Neoadjuvant dual checkpoint inhibition followed by immune-chemoradiation in patients with resectable gastric adenocarcinoma.

Abstract Poster

Authors

Cindy Pabon

Cindy M. Pabon

The University of Texas MD Anderson Cancer Center, Houston, TX

Cindy M. Pabon , Lianchun Xiao , Brian D. Badgwell , Paul F. Mansfield , Naruhiko Ikoma , Matheus Sewastjanow-Silva , Jeffrey H. Lee , Manoop S. Bhutani , Brian Weston , Emmanuel Coronel , Grace L. Smith , Emma Holliday , Jessie Tian , Prajnan Das , Bruce D. Minsky , Rebecca E Waters , Jeannelyn Estrella , Jenny Jing Li , Jaffer A. Ajani , Mariela A. Blum Murphy

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Local-Regional Disease

Clinical Trial Registration Number

NCT03776487

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 4067)

DOI

10.1200/JCO.2024.42.16_suppl.4067

Abstract #

4067

Poster Bd #

47

Abstract Disclosures

Similar Posters

First Author: Yara L. Verschoor

First Author: MARIA ALSINA

First Author: Ning Li

First Author: Ahmed Omar Kaseb